Home > Dail Eireann debate. Written answers 588, 589, 590, 591, 592, 596, 597, 598, 599, 601& 602 - Substance misuse [33851/17, 33852/17, 33853/17, 33854/17, 33855/17, 33859/17, 33860/17, 33861/17, 33862/17, 33862/17, 33864/17, 33865/17].

[Oireachtas] Dail Eireann debate. Written answers 588, 589, 590, 591, 592, 596, 597, 598, 599, 601& 602 - Substance misuse [33851/17, 33852/17, 33853/17, 33854/17, 33855/17, 33859/17, 33860/17, 33861/17, 33862/17, 33862/17, 33864/17, 33865/17]. (13 Jul 2013)


588. Deputy Jack Chambers asked the Minister for Health the number of adults who have been deemed appropriate for treatment for substance use to date in 2017 in each LHO; and the number who have received treatment within one calendar month. [33851/17]

 

589. Deputy Jack Chambers asked the Minister for Health the number of children who have been deemed appropriate for treatment for substance use to date in 2017 in each LHO; and the number who have received treatment within one week. [33852/17]

 

590. Deputy Jack Chambers asked the Minister for Health if he will report on the review of the services in all CHOs regarding the person-centred care planning processes of the drugs rehabilitation framework reassessment, key working and care planning. [33853/17]

 

591. Deputy Jack Chambers asked the Minister for Health the number of health service staff who are currently being trained on SAOR screening and brief intervention for problem alcohol and substance use. [33854/17]

592. Deputy Jack Chambers asked the Minister for Health the number of new persons who have been granted access to naloxone to date in 2017. [33855/17]

 

596. Deputy Jack Chambers asked the Minister for Health the increase in addiction residential treatment beds and additional treatment episodes which has been provided to date in 2017. [33859/17]

 

597.Deputy Jack Chambers asked the Minister for Health if he will report on the development of integrated care pathways and referral pathways from pharmacy needle exchange to other agencies. [33860/17]

 

598. Deputy Jack Chambers asked the Minister for Health if he will provide details of the expansion of other paraphernalia such as foil within the pharmacy needle exchange programme to allow clients the option of smoking rather than injecting. [33861/17]

 

599. Deputy Jack Chambers asked the Minister for Health the status of the guidelines and strategic statement on hidden harm. [33862/17]

 

601. Deputy Jack Chambers asked the Minister for Health the current average waiting time from referral to assessment for opioid substitution treatment. [33864/17]

 

602. Deputy Jack Chambers asked the Minister for Health the current average waiting time from opioid substitution assessment to exit from waiting list or treatment commenced. [33865/17]

 

Minister of State at the Department of Health (Deputy Catherine Byrne): I propose to take Questions Nos. 588 to 591, inclusive, 592, 596 to 599, inclusive, 601 and 602 together.

 

As these are service matters, they have been referred to the Health Service Executive for attention and direct reply to the Deputy.

 

See responses at http://www.hse.ie/eng/about/PersonalPQ/PQ/2017/July-2017/July-13.html

Item Type:Dail Debates
Source:Oireachtas
Date:13 July 2013
EndNote:View
Related URLs:
Subjects:B Substances > Opioids (opiates) > Opioid product > Naloxone
HJ Treatment method > Substance disorder treatment method
HJ Treatment method > Substance disorder treatment method > Substance replacement method (substitution)
HJ Treatment method > Psychosocial treatment method > Individual therapy > Brief intervention
J Health care, prevention and rehabilitation > Health related prevention > Health information and education > Communicable disease control > Needle distribution and exchange
J Health care, prevention and rehabilitation > Residential facility
VA Geographic area > Europe > Ireland

Repository Staff Only: item control page